A Facebook post says the pairing beat the 14.8% seen on high-dose tirzepatide alone, though 27% dropped out over side effects.
Recap by typeshit. Post by Facebook on Facebook.
A Future Health & Medical Innovation panel weighs how much of the growing interest in peptides and exosomes is backed by evidence.
The aging doctor shares a headline saying new studies point to GLP-1 drugs slowing the biological clock, and notes himself that more research is needed.
An explainer on how GLP-1 drugs act on reward and craving in the brain, and the research testing them against alcohol, nicotine and other substance use.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
Huberman says his REM sleep doubled, but Men's Health notes the evidence is mostly rat and small studies, with no safety research on pinealon injections.
Full ACHIEVE-4 results for orforglipron in type 2 diabetes, shown at EASD in Milan and in The Lancet, also report weight loss and lower blood pressure and triglycerides.
Loading…